Clarivate Plc(CLVT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.52 | Insider Own | 47.68% | Shs Outstand | 639.7M | Perf Week | 2.25% |
| Market Cap | 1.16B | Forward P/E | 2.35 | EPS next Y | 4.35% | Insider Trans | -0.52% | Shs Float | 334.7M | Perf Month | 6.43% |
| Enterprise Value | 5.20B | PEG | 0.28 | EPS next Q | 0.18 | Inst Own | 62.66% | Short Float | 13.98% | Perf Quarter | -15.35% |
| Income | -0.33B | P/S | 0.48 | EPS this Y | 7.39% | Inst Trans | 0.61% | Short Ratio | 10.68 | Perf Half Y | -27.49% |
| Sales | 2.41B | P/B | 0.26 | EPS next 5Y | 8.51% | ROA | -3.05% | Short Interest | 46.78M | Perf YTD | -45.51% |
| Book/sh | 7.09 | P/C | 5.35 | EPS past 3/5Y | 63.69% 16.31% | ROE | -7.01% | 52W High | -52.97% ($3.87) | Perf Year | -50.81% |
| Cash/sh | 0.34 | P/FCF | 3.55 | Sales past 3/5Y | -2.63% 14.38% | ROIC | -3.81% | 52W Low | 28.17% ($1.42) | Perf 3Y | -71.38% |
| Dividend Est. | - | EV/EBITDA | 5.58 | EPS Y/Y TTM | 16.13% | Gross Margin | 35.71% | Volatility(W/M) | 5.47% 5.78% | Perf 5Y | -91.79% |
| Dividend TTM | - | EV/Sales | 2.16 | Sales Y/Y TTM | -3.5% | Oper. Margin | 7.51% | ATR (14) | 0.1 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.85 | EPS Q/Q | -297.45% | Profit Margin | -13.84% | RSI (14) | 55.46 | Recom | 2.56 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.85 | Sales Q/Q | -5.49% | SMA20 | 8.92% ($1.67) | Beta | 1.38 | Target Price | $2.88 |
| Payout | - | Debt/Eq | 0.94 | Earnings | 2026/11/3 | SMA50 | -1.07% ($1.84) | Rel Volume | 0.5 | Prev Close | $1.87 |
| Employees | 12000 | LT Debt/Eq | 0.93 | EPS/Sales Surpr. | 4.97% -0.41% | SMA200 | -19.07% ($2.25) | Avg Volume(3M) | 4.38M | Price | $1.82 |
| IPO | 2018/10/29 | Option/Short | Yes/Yes | Trades | 6167 | Volume | 2,193,444 | Change | -2.67% |
📚 A global information services company that provides academic, intellectual property, and life sciences data and analytics services. It offers subscription-based access to academic research data, patent and trademark intellectual property information, and life sciences/healthcare data, and delivers solutions that combine data analytics with artificial intelligence capabilities. The company has established itself as a subscription-based information services provider specializing in professional data and analytics.
Over the past 1 year, on the lower side
53% below its 1-year high.
Traded less than usual. That is 50% of its average volume.
Next earnings report: November 3
7 days to go.
CLVT keeps an operating profit but posts a net loss
Of every $100 in sales, $7.51 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +7.4% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $48. Peers typically go for $69.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -91.8%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 62.7%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #39 of 81 in the industry
Based on market cap of $1B.
FAQ
What kind of company is CLVT?
CLVT belongs to the Technology sector and operates in the Information Technology Services industry.
What is the market cap of CLVT?
The market cap of CLVT is approximately $1.2B, ranking 2,470 within its sector.
What is the 52-week high and low for CLVT?
CLVT has recorded a 52-week high of $3.87 and a low of $1.42.